Latent Arterial Hypertension in Apparently Lone Atrial Fibrillation
- 74 Downloads
Introduction. Longitudinal studies on lone AF are rare and the incidence of hypertension in this population unknown. This study aimed at investigating the incidence of arterial hypertension in patients with apparently lone atrial fibrillation (AF).
Methods and Results. Out of 292 consecutive patients presented with permanent or paroxysmal AF, 32 patients were diagnosed as having lone AF according to strict criteria. Three patients were subjected to ablation of the ligament of Marshall, 14 patients to pulmonary vein isolation, and the remainder were treated with beta blockade. Patients were followed-up for a 1–3 year period. During follow-up, 14 patients were diagnosed as having arterial hypertension. Thirteen of them had recurrent AF despite ligament of Marshall ablation (1 patient), pulmonary vein isolation (4 patients) and beta blockade (8 patients). Cox regression analysis revealed that the only significant predictor of development of hypertension was complete or partial response to antiarrhythmic therapy (beta = 3.82, S.E. = 1.22, exp(b) = 45.63, 95% C.I. = 4.17–499.2, p = 0.001), independent of age (beta = −0.01, p = 0.74), sex (beta = −0.91, p = 0.28), left ventricular ejection fraction (beta = 0.06, p = 0.52), left atrial size (beta = 0.58, p = 0.7) and kind of antiarrhythmic therapy (ablation or drug therapy) (beta = 1.36, p = 0.09). In patients with lone AF that did not respond at all to antiarrhythmic therapy, there was a 45.6 times higher risk of diagnosing hypertension during the next 3 years as compared to responders.
Conclusion. Approximately 44% of patients with an initial diagnosis of lone AF may represent occult cases of arterial hypertension. In these patients hypertension may affect AF recurrence and treatment outcomes, regardless of the mode of antiarrhythmic therapy used.
Keywordslone atrial fibrillation hypertension
Unable to display preview. Download preview PDF.
- 4.The AFFIRM Investigators. A comparison of rate control and rhythm copntrol in patients with atrial fibrillation. N Engl J Med 2002;347:1825–1833.Google Scholar
- 5.Katritsis D, Panagiotakos DB, Karvouni E, Giazitzoglou E, Korovesis S, Paxinos G, Anagnostopoulos CE, Camm AJ. Is carvedilol superior to bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation? A randomised clinical trial. Am J Cardiol 2003;92:1116–1119.CrossRefPubMedGoogle Scholar
- 12.Katritsis DG, Ellenbogen KA, Panagiotakos DB, Giazitzoglou E, Karabinos I,Papadopoulos A, Zambartas C, Anagnostopoulos CE. Ablation of Superior Pulmonary Veins Compared to Ablation of All Four Pulmonary Veins:A Randomized Clinical Trial. J Cardiovasc Electrophysiol 2004;15:641–645.CrossRefPubMedGoogle Scholar
- 13.European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011–1053.Google Scholar
- 14.Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Me 2003;348:2407–2415.CrossRefGoogle Scholar
- 15.Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals:part 1:blood pressure measurement in humans:A statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Circulation 2005;111:697–716.CrossRefPubMedGoogle Scholar
- 16.Katritsis D, Ioannidis J, Anagnostopoulos CE, Sarris GE, Giazitzoglou E, Korovesis S, Camm AJ. Catheter ablation of extracardiac and intracardiac components of ligament of Marshall tissue:A novel approach for the treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2001;12:750–758.CrossRefPubMedGoogle Scholar
- 18.Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, Oh JK, Leibson C, Montgomery SC, Seward JB. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002;40:1636–1644.CrossRefPubMedGoogle Scholar
- 20.Madrid AH, Bueno MG, Rebollo JM, Marin I, Pena G, Bernal E, Rodriguez A, Cano L, Cano JM, Cabeza P, Moro C. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation:A prospective and randomized study. Circulation 2002;106:331–336.CrossRefPubMedGoogle Scholar